Surmodics

Vetex Medical is an Irish medical device company focused on developing innovative solutions for venous thromboembolism. The company has created a thrombectomy catheter that utilizes patented dynamic cage technology to effectively and efficiently remove thrombus from patients presenting with conditions such as deep vein thrombosis and pulmonary embolism. This device is designed to facilitate the predictable removal of wall-adherent thrombus in a single session, eliminating the need for thrombolytics. Initially, Vetex Medical will concentrate on treating patients with acute deep vein thrombosis in the ilio-femoral veins. The venous thrombectomy market has historically been underserved, but increasing clinical evidence and awareness are driving growth in this sector, positioning Vetex Medical as a key player in improving clinical outcomes and quality of life for patients affected by venous clot-related conditions.

NorMedix LLC is a medical device design and development company based in Plymouth, Minnesota, specializing in ultra-thin-walled, minimally invasive catheter technologies. The company provides a comprehensive range of services, including idea generation and product innovation, technical and market feasibility assessments, and prototype development. NorMedix also focuses on product development, offering design engineering, pre-clinical evaluations, and process development, along with verification and validation services that encompass design testing and clinical research. Additionally, the company manages manufacturing services, including finished device production and supply chain management. Its diverse product portfolio includes various medical devices such as guide catheters, crossing devices, embolic protection devices, and stent systems. As of January 2016, NorMedix operates as a subsidiary of SurModics, Inc.

Creagh Medical Limited is an Irish company specializing in the design, development, and manufacturing of medical devices, particularly angioplasty balloon catheters. Founded in 2006 and headquartered in Ballinasloe, Ireland, the company focuses on producing percutaneous transluminal angioplasty (PTA) balloon catheters for markets in Europe, the United States, and Japan. As of November 2015, Creagh Medical operates as a subsidiary of Surmodics, Inc. Through its innovative products, the company aims to enhance medical interventions in vascular procedures.

BioFX Laboratories is a manufacturer specializing in substrates, which are essential components in diagnostic test kits. These substrates play a crucial role in detecting and signaling chemical reactions, thereby facilitating accurate diagnostics in medical applications. By focusing on the production of high-quality substrates, BioFX Laboratories contributes significantly to the healthcare sector, supporting the development and effectiveness of various diagnostic tools.

Brookwood Pharmaceuticals, Inc., a leading provider of drug delivery technology primarily to the pharmaceutical industry.

InnoRx, Inc., a development stage company, develops novel therapies for the ophthalmology market. The company focuses on the development of drugs and drug delivery systems for ocular disease. Its products target age-related macular degeneration (AMD) and diabetic macular edema (DME).